Brittney M Snyder, Rebecca J Baer, Scott P Oltman, Jennifer G Robinson, Patrick J Breheny, Audrey F Saftlas, Wei Bao, Andrea L Greiner, Knute D Carter, Larry Rand, Laura L Jelliffe-Pawlowski, Kelli K Ryckman
AIMS: To evaluate the clinical utility of first and second trimester prenatal screening biomarkers for early pregnancy prediction of gestational diabetes mellitus (GDM) risk in nulliparous women. METHODS: We conducted a population-based cohort study of nulliparous women participating in the California Prenatal Screening Program from 2009 to 2011 (n = 105,379). GDM was ascertained from hospital discharge records or birth certificates. Models including maternal characteristics and prenatal screening biomarkers were developed and validated...
May 2020: Diabetes Research and Clinical Practice